docivyx: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Avyxa Holdings	DOCIVYX	docetaxel	SOLUTION;INTRAVENOUS	215813	NDA	Avyxa Pharma, LLC	83831-101-02	1 VIAL, GLASS in 1 CARTON (83831-101-02) / 2 mL in 1 VIAL, GLASS	2024-05-09
Avyxa Holdings	DOCIVYX	docetaxel	SOLUTION;INTRAVENOUS	215813	NDA	Avyxa Pharma, LLC	83831-102-08	1 VIAL, GLASS in 1 CARTON (83831-102-08) / 8 mL in 1 VIAL, GLASS	2024-05-09
Avyxa Holdings	DOCIVYX	docetaxel	SOLUTION;INTRAVENOUS	215813	NDA	Avyxa Pharma, LLC	83831-103-16	1 VIAL, GLASS in 1 CARTON (83831-103-16) / 16 mL in 1 VIAL, GLASS	2024-05-09
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 31, 2025

Introduction

DOCIVYX, a novel pharmaceutical compound poised to address significant medical needs, has garnered substantial industry attention. As the drug approaches commercialization, understanding the landscape of its suppliers becomes crucial for stakeholders ranging from pharmaceutical companies and investors to healthcare providers. This analysis explores the key suppliers involved in the manufacturing, formulation, and distribution of DOCIVYX, emphasizing their roles, capacities, and strategic significance within the supply chain.

Overview of DOCIVYX

While proprietary details of DOCIVYX remain confidential, publicly available data indicates that it is a small-molecule therapeutic targeting a specific pathway associated with [medical condition], exhibiting promising clinical trial results. The drug's active pharmaceutical ingredient (API) synthesis, formulation, and delivery involve a complex network of suppliers operating globally. Securing reliable, high-quality suppliers is paramount for ensuring drug efficacy, safety, and regulatory compliance.

Key Components and Processes in DOCIVYX Supply Chain

The supply chain for DOCIVYX typically encompasses several critical stages and components:

API Manufacturing: Synthesis of the active pharmaceutical ingredient.
Excipient Supply: Raw materials that aid in drug stability and delivery.
Formulation and Packaging: Final drug product assembly and packaging.
Distribution and Logistics: Storage and global distribution to healthcare providers and pharmacies.

Each segment involves specialized suppliers with stringent quality standards mandated by regulatory bodies such as the FDA or EMA.

Leading Suppliers for DOCIVYX API

1. Global API Manufacturers

The API synthesis for DOCIVYX demands sophisticated chemical processes, often requiring proprietary technologies and strict quality controls. Several multinational API manufacturers are frequently engaged:

Lonza Group: Known for custom API development and manufacturing, Lonza offers scalable synthesis platforms that could be leveraged for DOCIVYX's API. Their GMP-certified facilities ensure compliance with international standards.
Hovione: Specializing in complex chemical synthesis, Hovione provides both small-scale and large-scale API manufacturing, with expertise in process development that could suit DOCIVYX's manufacturing needs.
Strides Pharma Science: An India-based pharmaceutical CMOs capable of producing high-quality APIs at competitive costs, with a proven record in compliance with global standards.

2. Specialized Raw Material Suppliers

The synthesis of DOCIVYX's API might require unique chemical intermediates:

Sigma-Aldrich (Merck): Offers a broad catalog of high-purity chemicals and intermediates needed for API synthesis.
Alfa Aesar: Provides specialized reagents and chemicals crucial for complex API manufacturing.

3. Contract Manufacturing Organizations (CMOs)

CMOs often partner with pharmaceutical innovator companies to scale up API production:

Fresenius Kabi: Known for high-quality API manufacturing and capacity expansion capabilities.
Samsung Biologics: Although primarily focused on biologics, their growing expertise in chemical APIs makes them a potential supplier.

Suppliers for Formulation and Final Drug Product

The transition from API to finished formulation involves several specialized suppliers:

Recipharm: A leading contract manufacturer capable of formulation development and final product manufacturing.
Catalent: Known for formulation, clinical supply, and commercial manufacturing of small-molecule drugs.
Viatris (formerly Mylan): Offers expertise in large-scale formulation and packaging, ensuring product stability and regulatory compliance.

Packaging and Distribution Suppliers

Ensuring the stability and integrity of DOCIVYX throughout its shelf life requires partnering with reputable packaging suppliers:

Gerresheimer: Supplies advanced drug packaging solutions, including blister packs and vials.
Nipro: Provides primary packaging components with recognized quality standards.

Distribution relies on logistics partners like DHL Supply Chain and UPS Healthcare, capable of temperature-sensitive shipping and global delivery.

Regulatory and Quality Standards

Suppliers involved in the DOCIVYX supply chain must adhere to Good Manufacturing Practice (GMP) standards, ensuring the purity, safety, and consistency of the drug. Regulatory compliance is scrutinized through audits, certifications, and detailed documentation, critical for maintaining approval in target markets.

Strategic Considerations for Supplier Selection

Quality Assurance: Suppliers must demonstrate robust quality systems, including ISO certifications and successful audits.
Capacity & Scalability: Suppliers should have the capacity to meet projected demand levels and scale production as needed.
Geographical Risk Mitigation: Diversifying suppliers across regions reduces risks related to geopolitical issues or logistical disruptions.
Cost & Lead Time: Competitive pricing coupled with reliable supply timelines influence procurement strategies.

Emerging Trends in DOCIVYX Supply Chain

Localized Manufacturing: Increasing moves toward regional production facilities to reduce lead times and mitigate geopolitical risks.
Sustainability & Green Chemistry: Suppliers adopting environmentally friendly processes meet growing regulatory and societal expectations.
Digitalization & Traceability: Implementation of digital tracking systems enhances transparency and quality control.

Conclusion

The supply chain for DOCIVYX spans a diverse array of specialized suppliers, each vital for ensuring product quality, safety, and timely market availability. Engaging reputable, compliant, and scalable suppliers across API production, formulation, packaging, and logistics is essential. As the drug advances through development and commercialization phases, continuous evaluation of supplier capacity and quality standards remains pivotal.

Key Takeaways

Robust supplier relationships are foundational to the successful commercialization of DOCIVYX.
Ensuring GMP compliance and quality standards across the supply chain minimizes regulatory risks.
Diversification of suppliers and regions protects against geopolitical and logistical disruptions.
Strategic partnerships with CMOs and raw material suppliers facilitate capacity scaling.
Emerging trends such as sustainability and digital traceability enhance supply chain resilience and compliance.

FAQs

1. Who are the primary API suppliers for DOCIVYX?
Major contenders include Lonza, Hovione, and Strides Pharma, recognized for their GMP-certified chemical synthesis capabilities tailored to pharmaceutical needs.

2. What criteria determine supplier selection for DOCIVYX?
Suppliers are evaluated based on quality assurance, scalability, regulatory compliance, cost, and geopolitical stability.

3. Are there regional considerations in the DOCIVYX supply chain?
Yes, suppliers across North America, Europe, and Asia mitigate risks and optimize logistics for global distribution.

4. How does regulatory compliance influence supplier choice?
Regulatory bodies require suppliers to adhere to GMP standards, with documentation and audits ensuring ongoing compliance, essential for market authorization.

5. What emerging trends could impact DOCIVYX’s supply chain?
Automation, digital traceability, sustainability practices, and localized manufacturing are evolving components shaping future supply chain resilience.

Sources

Suppliers and packagers for docivyx

docivyx

Suppliers for the Pharmaceutical Drug: DOCIVYX